3 Top Healthcare Stocks to Buy in October
Healthcare stocks have underperformed the broader market over the past year, weighed down by political tensions and policy uncertainty following the transition to the TRUMP administration. Despite these headwinds, the sector remains a core pillar of the economy, driven by constant demand for care and medical innovation.
Novo Nordisk, a key player in the weight-loss drug market, has seen its shares plummet by 50% due to competition from compounding pharmacies. The company recently replaced its CEO and is taking a more aggressive stance against these competitors while preparing to launch an oral tablet version of its blockbuster drug, Wegovy.